» Articles » PMID: 37705748

Sirtuin-3 Activates the Mitochondrial Unfolded Protein Response and Reduces Cerebral Ischemia/reperfusion Injury

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2023 Sep 14
PMID 37705748
Authors
Affiliations
Soon will be listed here.
Abstract

Sirtuin-3 (Sirt3) deacetylates several mitochondrial proteins implicated into cerebral ischemia/reperfusion (I/R) injury. The mitochondrial unfolded protein response (UPR) favors mitochondrial proteostasis during various stressors. Here, we used Sirt3 transgenic mice and a transient middle cerebral artery occlusion model to evaluate the molecular basis of Sirt3 on the UPR during brain post-ischemic dysfunction. The present study illustrated that Sirt3 abundance was suppressed in the brain after brain ischemic abnormalities. Overexpression of Sirt3 suppressed the infarction size and attenuated neuroinflammation after brain I/R injury. Sirt3 overexpression restored neural viability by reducing mitochondrial ROS synthesis, maintaining the mitochondrial potential and improving mitochondrial adenosine triphosphate synthesis. Sirt3 overexpression protected neuronal mitochondria against brain post-ischemic malfunction via eliciting the UPR by the forkhead box O3 (Foxo3)/sphingosine kinase 1 (Sphk1) pathway. Inhibiting either the UPR or the Foxo3/Sphk1 pathway relieved the favorable influence of Sirt3 on neural function and mitochondrial behavior. In contrast, Sphk1 overexpression was sufficient to reduce the infarction size, attenuate neuroinflammation, sustain neuronal viability and prevent mitochondrial abnormalities during brain post-ischemia dysfunction. Thus, the UPR protects neural viability and mitochondrial homeostasis, and the Sirt3/Foxo3/Sphk1 pathway is a promosing therapeutic candidate for ischemic stroke.

Citing Articles

Mechanism of Formononetin in Improving Energy Metabolism and Alleviating Neuronal Injury in CIRI Based on Nontargeted Metabolomics Research.

Zhao J, Zhang Y, Lv S, Wang F, Shan T, Wang J J Cell Mol Med. 2025; 29(4):e70340.

PMID: 39993962 PMC: 11850093. DOI: 10.1111/jcmm.70340.


Insight into interplay between PANoptosis and autophagy: novel therapeutics in ischemic stroke.

Tian H, Lei Y, Zhou J, Liu L, Yang T, Zhou Y Front Mol Neurosci. 2025; 17():1482015.

PMID: 39846000 PMC: 11751022. DOI: 10.3389/fnmol.2024.1482015.


The mitochondria as a potential therapeutic target in cerebral I/R injury.

Fang S, Huang W, Qu X, Chai W Front Neurosci. 2025; 18():1500647.

PMID: 39844858 PMC: 11752919. DOI: 10.3389/fnins.2024.1500647.


ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke.

Filippenkov I, Shpetko Y, Stavchansky V, Denisova A, Gubsky L, Andreeva L Biomedicines. 2025; 12(12.

PMID: 39767736 PMC: 11673339. DOI: 10.3390/biomedicines12122830.


Sphk1/S1P pathway promotes blood-brain barrier breakdown after intracerebral hemorrhage through inducing Nlrp3-mediated endothelial cell pyroptosis.

Feng M, An Y, Qin Q, Fong I, Zhang K, Wang F Cell Death Dis. 2024; 15(12):926.

PMID: 39715736 PMC: 11666774. DOI: 10.1038/s41419-024-07310-4.


References
1.
Wu M, Gu X, Ma Z . Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury. Mol Neurobiol. 2021; 58(10):5253-5271. DOI: 10.1007/s12035-021-02494-8. View

2.
Li X, Li H, Xu Z, Ma C, Wang T, You W . Ischemia-induced cleavage of OPA1 at S1 site aggravates mitochondrial fragmentation and reperfusion injury in neurons. Cell Death Dis. 2022; 13(4):321. PMC: 8993832. DOI: 10.1038/s41419-022-04782-0. View

3.
Chang X, Li Y, Cai C, Wu F, He J, Zhang Y . Mitochondrial quality control mechanisms as molecular targets in diabetic heart. Metabolism. 2022; 137:155313. DOI: 10.1016/j.metabol.2022.155313. View

4.
Zeng M, Zhou H, He Y, Wang Z, Shao C, Yin J . Danhong injection alleviates cerebral ischemia/reperfusion injury by improving intracellular energy metabolism coupling in the ischemic penumbra. Biomed Pharmacother. 2021; 140:111771. DOI: 10.1016/j.biopha.2021.111771. View

5.
Zou R, Tao J, Qiu J, Lu H, Wu J, Zhu H . DNA-PKcs promotes sepsis-induced multiple organ failure by triggering mitochondrial dysfunction. J Adv Res. 2022; 41:39-48. PMC: 9637726. DOI: 10.1016/j.jare.2022.01.014. View